Kelly Hollis

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Filter by Publication Topic

Search Results

Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat

Anaphylaxis in schools: Results of the EPIPEN4SCHOOLS survey combined analysis

Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools: results from the EpiPen4Schools(®) pilot survey

Anaphylaxis triggers and treatments by grade level and staff training: Findings from the EPIPEN4SCHOOLS pilot survey

Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools: results from the EpiPen4Schools® pilot survey

Assure-Csu: Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity: Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity [MEETING ABSTRACT PSS17]

EPIPEN4SCHOOLS® Survey Combined Analysis: Staff Training and Use of Epinephrine Auto-Injectors

EPIPEN4SCHOOLS® survey combined analysis: Prevalence and triggers of anaphylactic events

The Epipen4schools(R) Survey: Staff Training And Use Of Epinephrine Auto-Injectors For The Treatment Of Anaphylaxis In Large Us School Districts

Work productivity and activity impairment among chronic spontaneous/idiopathic urticaria patients: Results from the first international burden of illness study (assure-csu)

Healthcare resource utilisation among chronic spontaneous/idiopathic urticaria patients- findings from the first international burden of illness study (assure-csu)

First real-world study assessing health utility values for chronic spontaneous/idiopathic urticaria using the eq-5d

Differences in anaphylaxis-related risks by school grade level: Findings from the EPIPEN4SCHOOLS (R) survey

ASSURE-CSU: A real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria

EpiPen4Schools pilot survey: Occurrence of anaphylaxis, triggers, and epinephrine administration in a U.S. school settings

Availability and use of epinephrine auto-injectors for the treatment of anaphylaxis: Results from the Epipen4schools® survey

Assure-Csu Canadian results: Assessing health utility in chronic spontaneous/idiopathic urticaria using the Eq-5D

Assure-Csu Canadian results: Assessing the impact of chronic spontaneous/idiopathic urticaria on work productivity and indirect costs

Epinephrine administration for cases of anaphylaxis in a US school setting: Results from the EpiPen4Schools survey

Occurrence of anaphylaxis by school grade level and staff training: Findings from the EpiPen4Schools survey